Back to 
Steward Partners Investment Advisory, LLC
Steward Partners Investment Advisory, LLC
ARQT
14 quarters
Position history for Steward Partners Investment Advisory, LLC's holdings in Arcutis Biotherapeutics, Inc.
Yes. Steward Partners Investment Advisory holds 500 shares of ARQT (Arcutis Biotherapeutics), worth $13,110, as of its Q2 2026 13F filing. It reduced the position by 113 shares (-18.4%) from Q1 2026. Steward Partners Investment Advisory has held ARQT since Q2 2025, across 5 quarterly 13F filings.
Current Value
$13,110
Current Shares
500
Total Value Change
+$10,110
Total Shares Change
+400
Quarter-by-Quarter History
Other major holders of ARQT: BlackRock, Inc., Jennison Associates LLC, FMR LLC